In notable stock market news, Nutrien (NTR, Financial) has been downgraded by Raymond James, an influential player in financial analysis. The advisory firm, represented by analyst Steve Hansen, shifted its rating for Nutrien from "Outperform" to "Market Perform" as of June 17, 2025.
Despite the rating change, the price target for Nutrien (NTR, Financial) remains steady. Hansen has maintained the price target at $68.00 USD, indicating no change from prior assessments. This indicates a consistent outlook on Nutrien’s market value amid current market conditions.
Shares of Nutrien (NTR, Financial) continue to be monitored closely as investors digest the implications of this analyst rating adjustment. The unchanged price target suggests that while the growth prospects in the immediate term may have been reassessed, the valuation remains consistent with previous estimates.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Nutrien Ltd (NTR, Financial) is $63.35 with a high estimate of $70.00 and a low estimate of $56.00. The average target implies an upside of 2.08% from the current price of $62.06. More detailed estimate data can be found on the Nutrien Ltd (NTR) Forecast page.
Based on the consensus recommendation from 23 brokerage firms, Nutrien Ltd's (NTR, Financial) average brokerage recommendation is currently 2.3, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Nutrien Ltd (NTR, Financial) in one year is $49.79, suggesting a downside of 19.77% from the current price of $62.06. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Nutrien Ltd (NTR) Summary page.
